Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.46 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.45 |
| ▸ | DDO | Q99489 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3668045 | 0.92 | HTT (0.48) | LMNAHTTKDM4EPKMMEN1 | |
| SCHEMBL27705068 | 0.88 | LMNA (0.50) | LMNAHTTKDM4EPKMMEN1 | |
| SCHEMBL9716925 | 0.88 | LMNA (0.50) | LMNAHTTKDM4EPKMMEN1 | |
| SCHEMBL2065604 | 0.86 | LMNA (0.48) | LMNAHTTKDM4EPKMMEN1 | |
| SCHEMBL26565516 | 0.85 | LMNA (0.43) | LMNAHTTKDM4EPKMMEN1 | |
| SCHEMBL10870053 | 0.85 | PKM (0.50) | LMNAHTTKDM4EPKMMEN1 | |
| SCHEMBL4625912 | 0.85 | HTT (0.43) | LMNAHTTKDM4EPKMMEN1 | |
| SCHEMBL1101881 | 0.85 | LMNA (0.52) | LMNAHTTKDM4EPKMMEN1 | |
| SCHEMBL25280341 | 0.82 | DAO (0.47) | LMNAHTTKDM4EPKMMEN1 | |
| SCHEMBL12377557 | 0.82 | LMNA (0.45) | LMNAHTTKDM4EPKMMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010014361-A1 | NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI- INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES | EDISON PHARMACEUTICALS, INC. (US) | 2010-02-04 | — | — | WO | claimed |
| US-20100029784-A1 | NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI-INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES | AMPERE LIFE SCIENCES, INC. | 2010-02-04 | — | — | US | claimed |
| WO-2023151942-A1 | DEVICE FOR CONVERTING THERMAL ENERGY OF AN EXTERNAL HEAT SOURCE INTO ELECTRICAL ENERGY | HAESE FRANK (DE) | 2023-08-17 | — | — | WO | disclosed |
| EP-4227604-A1 | DEVICE FOR CONVERTING THERMAL ENERGY OF AN EXTERNAL HEAT SOURCE INTO ELECTRICAL ENERGY | Haese, Frank (DE) | 2023-08-16 | — | — | EP | disclosed |
| EP-3620459-B1 | PHOSPHORUS-CONTAINING PHENOLIC COMPOUND, PHOSPHORUS-CONTAINING EPOXY RESIN, CURABLE RESIN COMPOSITION THEREOF, OR EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF | NIPPON STEEL CHEMICAL & MAT CO LTD (JP) | 2023-05-24 | — | — | EP | disclosed |
| WO-2010035000-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010014361-A1 | NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI- INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES | EDISON PHARMACEUTICALS, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| WO-2010014361-A1 | NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI- INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES | EDISON PHARMACEUTICALS, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| US-20100029784-A1 | NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI-INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES | AMPERE LIFE SCIENCES, INC. | 2010-02-04 | — | — | US | disclosed |
| US-20100029784-A1 | NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI-INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES | AMPERE LIFE SCIENCES, INC. | 2010-02-04 | — | — | US | disclosed |
| US-20100029784-A1 | NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI-INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES | AMPERE LIFE SCIENCES, INC. | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029784-A1 | NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI-INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES | NFE2L2, NQO1, POT1 | LMNA 156/4885HTT 123/4885KDM4E 2674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.